
Overview
Dr. Mary Wilkinson is a medical oncologist caring for patients with breast cancer and gyn malignancies. Dr. Wilkinson sees patients primarily at Sibley Memorial Hospital in Washington DC. She also serves as clinical director of the Under Armour Breast Health Innovation Center at the Sidney Kimmel Comprehensive Cancer Center. Dr. Wilkinson received her undergraduate degree in electrical engineering from Rice University and earned her M.D. from Stanford University School of Medicine. She completed her residency and performed a fellowship in hematology and oncology at the University of California, San Francisco. Dr. Wilkinson joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Wilkinson was director of breast cancer research at the Inova Schar Cancer Institute and president of Medical Oncology Hematology Associates of Northern Virginia. She also spent time on the faculty at Georgetown University and the University of California, San Francisco. Dr. Wilkinson is a member of the American Society of Clinical Oncology.
Dr. Wilkinson is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer.
Her clinical research consists of co-authoring 8 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Building B, Washington, DC 20016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
12 Clinical Trials
Sidney Kimmel Comprehensive Cancer Center
Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner is rated as an Elite provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
American Oncology Partners PA
David Smith is a Hematologist and an Oncologist in Easton, Maryland. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Adult Immune Thrombocytopenia, and Myelodysplastic Syndrome (MDS).
Maryland Oncology Hematology PA
Sadaf Taimur is a Hematologist Oncology specialist and a Hematologist in Brandywine, Maryland. Dr. Taimur is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Paget Disease of the Breast, and Pulmonary Embolism. Dr. Taimur is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Wilkinson isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Wilkinson isDistinguished. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Wilkinson isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Wilkinson isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Endometrial CancerDr. Wilkinson isAdvanced. Learn about Endometrial Cancer.
- Malignant Mixed Mullerian TumorDr. Wilkinson isAdvanced. Learn about Malignant Mixed Mullerian Tumor.
- Ovarian CarcinosarcomaDr. Wilkinson isAdvanced. Learn about Ovarian Carcinosarcoma.
- Virilizing Ovarian TumorDr. Wilkinson isAdvanced. Learn about Virilizing Ovarian Tumor.
- Experienced
- Adult Soft Tissue SarcomaDr. Wilkinson isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Anal CancerDr. Wilkinson isExperienced. Learn about Anal Cancer.
- Appendix CancerDr. Wilkinson isExperienced. Learn about Appendix Cancer.
- Breast Cancer in MenDr. Wilkinson isExperienced. Learn about Breast Cancer in Men.
- Cervical CancerDr. Wilkinson isExperienced. Learn about Cervical Cancer.
- Colorectal CancerDr. Wilkinson isExperienced. Learn about Colorectal Cancer.
